Author:
MacLennan David H.,Britt Beverley A.
Reference52 articles.
1. Adeokun AM, West SP, Ellis FR, et al. The GI 021A substitution in the RYR1 gene does not cosegregate with malignant-hyperthermia susceptibility in a British pedigree. Am J Hum Genet 1997; 60: 833–841.
2. Allen GC, Larach MG, Kunselman AR. The sensitivity and specificity of the caffeine halothane contracture test: a report from the North American Malignant Hyperthermia Registry. Anesthesiology, 1998; in press.
3. Ball SP, Johnson KJ. The genetics of malignant hyperthermia. J Med Genet 1993; 30: 89–93.
4. Berman MC, Harrison GG, Bull AB, Kench JE. Changes underlying halothane-induced malignant hyperthermia in Landrace pigs. Nature 1970; 225: 653–655.
5. Britt BA. Malignant hyperthermia: a review. In: Schonbaum E, Lomax P, eds. Thermoregulation: pathology, pharmacology and therapy. New York: Pergamon, 1991; pp. 179–292.